View Older Stories View More Recent Stories

Jan 8, 2026 08:33AM SOL Strategies reports 523,134 SOL holdings worth CAD101.5 million
Jan 8, 2026 08:30AM SOL Strategies December 2025 Monthly Business Update
Jan 8, 2026 07:47AM Compass Pathways (CMPS) Reiterated at Market Outperform by Cantor Fitzgerald
Jan 8, 2026 07:45AM D-Wave Quantum (QBTS) Reiterated at Market Outperform by Cantor Fitzgerald
Jan 8, 2026 07:44AM Eli Lilly (LLY) Reiterated at Overweight by Cantor Fitzgerald
Jan 8, 2026 06:33AM Cantor Fitzgerald Reiterates Overweight Rating on SoundHound AI Inc. (SOUN)
Jan 8, 2026 02:16AM Meta Platforms Inc. (META) PT Raised to $750 at Cantor Fitzgerald
Jan 8, 2026 02:15AM Cantor Fitzgerald Starts Reddit (RDDT) at Neutral
Jan 8, 2026 02:14AM Cantor Fitzgerald Upgrades Airbnb Inc. (ABNB) to Neutral
Jan 8, 2026 02:14AM Cantor Fitzgerald Upgrades Alphabet (GOOGL) to Overweight
Jan 7, 2026 10:52PM Alumis prices $300 million stock offering at $17 per share
Jan 7, 2026 10:52PM Alumis Announces Pricing of Upsized Public Offering of Common Stock
Jan 7, 2026 10:33PM Phathom Pharmaceuticals prices $130 million stock offering
Jan 7, 2026 10:33PM Phathom Pharmaceuticals prices $130 million public offering
Jan 7, 2026 10:33PM Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants
Jan 7, 2026 10:33PM Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants
Jan 7, 2026 09:34PM Bright Minds Biosciences prices $175 million stock offering
Jan 7, 2026 09:33PM Bright Minds Biosciences prices $175 million stock offering at $90 per share
Jan 7, 2026 09:33PM Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock
Jan 7, 2026 09:33PM Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock
Jan 7, 2026 05:18PM Lilly moves beyond blockbuster obesity drugs with $1.2 billion Ventyx buy
Jan 7, 2026 05:01PM Form 8-K Cantor Fitzgerald Income For: Jan 01
Jan 7, 2026 04:05PM Phathom Pharmaceuticals announces public stock offering
Jan 7, 2026 04:05PM Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Jan 7, 2026 09:35AM Varonis Systems (VRNS) PT Lowered to $50 at Cantor Fitzgerald
Jan 7, 2026 09:33AM Cantor Fitzgerald Downgrades BigBear.ai Holdings (BBAI) to Neutral
Jan 7, 2026 09:32AM Cantor Fitzgerald Downgrades SoundThinking (SSTI) to Neutral
Jan 7, 2026 09:29AM Cantor Fitzgerald Downgrades GitLab Inc (GTLB) to Neutral
Jan 7, 2026 09:27AM JFrog (FROG) PT Raised to $80 at Cantor Fitzgerald
Jan 7, 2026 07:45AM Arrowhead Pharma (ARWR) Reiterated at Overweight by Cantor Fitzgerald
Jan 7, 2026 07:01AM SharkNinja appoints Jason Wortendyke to board of directors
Jan 7, 2026 07:00AM SharkNinja Appoints Jason Wortendyke to Its Board of Directors
Jan 7, 2026 06:37AM Cantor: 'Large Cap Top Pick: CrowdStrike'
Jan 7, 2026 06:30AM EnviroGold Delivers Strong 2025 Execution and Establishes a Clear Path to Commercial Growth in 2026
Jan 6, 2026 04:12PM Alumis plans $175 million public stock offering
Jan 6, 2026 04:12PM Alumis Announces Proposed Public Offering of Common Stock
Jan 6, 2026 04:00PM Bright Minds Biosciences launches $100 million public offering
Jan 6, 2026 04:00PM Bright Minds Biosciences Announces Launch of US$100 Million Public Offering
Jan 6, 2026 07:25AM Celldex Therapeutics (CLDX) Reiterated at Overweight by Cantor Fitzgerald
Jan 6, 2026 07:10AM Structure Therapeutics (GPCR) Reiterated at Overweight by Cantor Fitzgerald
Jan 5, 2026 08:04AM Xenon Pharmaceuticals (XENE) PT Raised to $55 at Cantor Fitzgerald
Jan 5, 2026 08:01AM CoreWeave (CRWV) Well-Positioned to Benefit From AI Hyperscale Demand: Analyst
Jan 5, 2026 08:00AM Hyperion DeFi appoints Hyunsu Jung as chief executive officer
Jan 5, 2026 08:00AM Cantor Fitzgerald Reiterates Overweight Rating on ServiceNow (NOW) as TAM Expands Through M&A
Jan 5, 2026 08:00AM Hyperion DeFi Appoints Hyunsu Jung as Chief Executive Officer
Jan 5, 2026 07:57AM Cantor Fitzgerald Highlights Okta, Inc (OKTA) Stock as a Contrarian Play
Jan 5, 2026 07:54AM Cantor Fitzgerald Reiterates Overweight Rating on Stoke Therapeutics (STOK)
Jan 5, 2026 07:51AM Cantor Fitzgerald: We expect Semiconductors to Outperform in 2026.
Jan 5, 2026 07:47AM Cantor Fitzgerald on Intuitive Machines Inc. (LUNR): 'We Remain Very Bullish...Ahead of Near-Term Catalysts'
Jan 5, 2026 07:45AM Cantor Fitzgerald Reiterates Overweight Rating on Rocket Lab USA (RKLB)
View More Recent Stories View Older Stories